04 Jan PRVB closing out for 70% final gains
PRVB 17.60 It's up today in a down market on the FDA accepting the BLA for Teplizumab. That said, we are taking the gains of 70% on the final 1/2 after 18 months of holding this stock. This could continue to work higher but we are...